Ticker

No recent analyst price targets found for MWAI.

Latest News for MWAI

MedWell Ai Reports Strong Q2 Revenues Of $548,315 And Provides Guidance For Full Year 2025 Exceeding $2,200,000

CLEARWATER, Fla., Feb. 23, 2026 (GLOBE NEWSWIRE) -- via IBN -- MedWell Ai, Inc, (OTCQB: MWAI ) ("Company") is a portfolio company, specializing in AI-driven solutions for B2B markets in pharmaceuticals, healthcare, and wellness, is pleased to confirm the filing, after the market close, of its Quarterly Report (Form 10-Q), for the financial period, ending on December 31, 2025.

GlobeNewsWire • Feb 23, 2026
Apollo Biowellness Executes Letter Of Intent with Medwell AI, Inc.

North Bergen, New Jersey--(Newsfile Corp. - February 10, 2026) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company) is pleased to announce the signing of a Letter of Intent ("LOI") to create a vertically integrated health, wellness and longevity platform. To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/10533/283349_a912020384f54aed_001full.jpg New MedWell Ai, Inc…

Newsfile Corp • Feb 10, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for MWAI.

No House trades found for MWAI.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top